We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+13.01%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$26B
AUM Growth
+$2.7B
Cap. Flow
-$57.1M
Cap. Flow %
-0.22%
Top 10 Hldgs %
42.98%
Holding
282
New
15
Increased
82
Reduced
90
Closed
11

Top Buys

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$21.2M
2
PGR icon
Progressive
PGR
+$20.5M
3
INTU icon
Intuit
INTU
+$20.4M
4
INFO
IHS Markit Ltd. Common Shares
INFO
+$18.3M
5
AMZN icon
Amazon
AMZN
+$10.4M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$36.6M
2
AAPL icon
Apple
AAPL
+$30.9M
3
CB icon
Chubb
CB
+$21.2M
4
ABBV icon
AbbVie
ABBV
+$11.6M
5
ASML icon
ASML
ASML
+$8.35M

Sector Composition

Rank Sector Weight
1 Technology 21.9%
2 Financials 19.28%
3 Consumer Staples 19.24%
4 Communication Services 10.61%
5 Healthcare 9.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EV
26
DELISTED
Eaton Vance Corp.
EV
$351M 1.35%
5,160,000
NVO
27
Novo Nordisk
NVO
$208B
$348M 1.34%
9,966,894
-33,460
-0.3% -$1.16M
UNH icon
28
UnitedHealth
UNH
$376B
$331M 1.27%
943,226
+7,672
+0.8% +$2.57M
JNJ icon
29
Johnson & Johnson
JNJ
$618B
$330M 1.27%
2,099,679
-17,656
-0.8% -$2.61M
ABBV icon
30
AbbVie
ABBV
$443B
$328M 1.26%
3,059,997
-121,006
-4% -$11.6M
BNY
31
Bank of New York Mellon
BNY
$106B
$314M 1.21%
7,394,174
EPD icon
32
Enterprise Products Partners
EPD
$82.3B
$312M 1.2%
15,945,252
-48,116
-0.3% -$896K
DIS icon
33
Walt Disney
DIS
$167B
$299M 1.15%
1,647,891
-48,438
-3% -$6.95M
ASML icon
34
ASML
ASML
$626B
$289M 1.11%
591,528
-19,840
-3% -$8.35M
MRK icon
35
Merck
MRK
$322B
$272M 1.04%
3,480,851
+59,836
+2% +$4.58M
CP icon
36
Canadian Pacific Kansas City
CP
$78.1B
$270M 1.04%
3,893,745
-24,450
-0.6% -$1.59M
PGR icon
37
Progressive
PGR
$123B
$263M 1.01%
2,660,200
+217,020
+9% +$20.5M
ICE icon
38
Intercontinental Exchange
ICE
$85.6B
$240M 0.92%
2,080,297
+23,312
+1% +$2.42M
ISRG icon
39
Intuitive Surgical
ISRG
$127B
$237M 0.91%
869,931
-2,256
-0.3% -$560K
XOM icon
40
ExxonMobil
XOM
$644B
$213M 0.82%
5,160,429
-976,403
-16% -$36.6M
NKE icon
41
Nike
NKE
$61.9B
$190M 0.73%
1,345,297
-13,537
-1% -$1.79M
MA icon
42
Mastercard
MA
$502B
$181M 0.7%
507,309
+5,225
+1% +$1.74M
KMI icon
43
Kinder Morgan
KMI
$71.7B
$177M 0.68%
12,926,622
-406,715
-3% -$5.44M
INTU icon
44
Intuit
INTU
$86.5B
$176M 0.67%
462,577
+58,024
+14% +$20.4M
ADP icon
45
Automatic Data Processing
ADP
$106B
$175M 0.67%
994,143
-6,388
-0.6% -$1.05M
ADBE icon
46
Adobe
ADBE
$99.5B
$173M 0.66%
345,964
+43,862
+15% +$21.2M
SHW icon
47
Sherwin-Williams
SHW
$82.7B
$150M 0.58%
612,555
-1,410
-0.2% -$334K
BRK.A icon
48
Berkshire Hathaway Class A
BRK.A
$1.1T
$143M 0.55%
410
-8
-2% -$2.65M
VRSK icon
49
Verisk Analytics
VRSK
$25.4B
$128M 0.49%
617,083
-2,060
-0.3% -$400K
WMT icon
50
Walmart Inc
WMT
$885B
$125M 0.48%
2,599,536
-20,337
-0.8% -$988K

Similar funds

Fayez Sarofim & Co's Q4 2020 Portfolio in Review

As of Q4 2020, Fayez Sarofim & Co held 282 positions worth $26B, up 12% from $23.3B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Fayez Sarofim & Co's Q4 2020 filing shows 15 new, 82 increased, 90 reduced and 11 closed positions. Its largest new stake was Viatris: 86,257 shares worth $1.62M. The largest sale was ExxonMobil, an estimated $36.6M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Staples.

  • Fayez Sarofim & Co's largest Q4 2020 buy was Viatris: 86,257 shares worth $1.62M.
  • Fayez Sarofim & Co added most to Adobe in Q4 2020, an estimated $21.2M increase.
  • Fayez Sarofim & Co's biggest Q4 2020 reduction was ExxonMobil, cutting an estimated $36.6M.
  • Fayez Sarofim & Co fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $3.64M.
  • Fayez Sarofim & Co's ten largest holdings make up 43% of its $26B portfolio in Q4 2020.
  • Fayez Sarofim & Co opened 15 new positions and closed 11 in Q4 2020.
  • Fayez Sarofim & Co's portfolio value rose 12% quarter-over-quarter to $26B.

Based on Fayez Sarofim & Co's 13F filing for Q4 2020, filed 11 Feb 2021.